GUANGDONG RAFFLES PHARMATECH CO LTD

Overview

GUANGDONG RAFFLES PHARMATECH CO LTD is an active pharmaceutical ingredient (API) supplier with 3 active FDA Type II Drug Master Files, covering (5R)-5-(2,2-DIMETHYL-4H-1,3-BENZODIOXIN-6-YL)-1,3-OXAZOLIDIN-2-ONE (VILANTEROL OXAZOLIDINONE INTERMEDIATE); DABRAFENIB MESYLATE; ELTROMBOPAG OLAMINE.

API / Drug Master Files

GUANGDONG RAFFLES PHARMATECH CO LTD holds 3 active (3 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• DABRAFENIB MESYLATEActive2025-12-31
• ELTROMBOPAG OLAMINEActive2023-09-27
• (5R)-5-(2,2-DIMETHYL-4H-1,3-BENZODIOXIN-6-YL)-1,3-OXAZOLIDIN-2-ONE (VILANTEROL OXAZOLIDINONE INTERMEDIATE)Active2020-07-06

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to GUANGDONG RAFFLES PHARMATECH CO LTD in our records. PharmaTek screens the full directory against live FDA enforcement data.